Rabies DNA vaccine: No impact of MHC Class I and Class II targeting sequences on immune response and protection against lethal challenge

Rabies is progressive fatal encephalitis. WHO estimates 55,000 rabies deaths and more than 10 million PEP every year world-wide. A variety of cell-culture derived vaccines are available for prophylaxis against rabies. However, their high cost restricts their usage in developing countries, where such...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Manpreet, Rai, Anant, Bhatnagar, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115670/
https://www.ncbi.nlm.nih.gov/pubmed/19356616
http://dx.doi.org/10.1016/j.vaccine.2009.01.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115670/
https://www.ncbi.nlm.nih.gov/pubmed/19356616
http://dx.doi.org/10.1016/j.vaccine.2009.01.128

Ejemplares similares